Cizzle Bio has developed a non-invasive blood test to help detect gastric cancer in its earliest and most treatable stages.

Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known as SWIFT-seq, ...

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...

Experts don't back specific tests, but provide guidelines on how doctors in specialty care settings can use them to diagnose ...

Expanding the use of Alzheimer's blood tests is crucial to usher in a new era of precision medicine and bring Alzheimer's ...

A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.

They developed a new blood test that uses RNA instead of DNA. This test detected early-stage colorectal cancer with 95% accuracy. That is a major improvement over current non-invasive tests.

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of the Vanguard Study — which will include up to 24,000 people ...

Adding the Fujirebio test to our existing blood-based tests provides the many physicians we serve with another powerful option for assessing patients for Alzheimer's disease," said Kathleen Valentine, ...

Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect™ product line for assessing symptomatic patients SECAUCUS, N.J ...